血清25-羟维生素D水平对血液透析患者脆性骨折的影响
本研究在292例稳定维持性血液透析门诊患者中,探讨基线血清25-羟维生素D(25(OH)D)水平与新发脆性骨折的关联。中位随访24个月期间发生49例(16.8%)骨折,多因素Cox回归显示25(OH)D每增加10 nmol/L与骨折风险降低独立相关(aHR 0.83,95%CI 0.68-0.99,p=0.046)。
要点
- 血液透析患者中,较低的血清25(OH)D水平与新发脆性骨折风险升高独立相关。
- 25(OH)D每升高10 nmol/L,骨折风险降低(aHR 0.83,95%CI 0.68-0.99)。
- 按25(OH)D中位数分层,低值组和高值组累积骨折发生率分别为24.3%和11.9%。
核心结论
- 在肾脏维生素D活化受损的血液透析患者中,较低的血清25(OH)D水平与新发脆性骨折风险升高独立相关,且不受传统骨折危险因素或影响维生素D状态的变量影响。
- 循环25(OH)D水平或可作为血液透析患者骨折风险的预测指标。
研究设计与样本
- 研究纳入292例稳定维持性血液透析门诊患者,测量血清25(OH)D水平,分析基线25(OH)D状态与新发脆性骨折发生率之间的关联。
- 随访中位时间为24个月。
主要发现
- 随访期间共发生49例(16.8%)骨折。
- 多因素Cox回归分析显示,血清25(OH)D水平每增加10 nmol/L与骨折风险降低显著相关(校正风险比[aHR] 0.83,95%置信区间[CI] 0.68-0.99,p=0.046)。
- 按25(OH)D中位数分层,低值组和高值组的累积骨折发生率分别为24.3%和11.9%(aHR 1.87,95%CI 1.02-3.42,p=0.041)。
临床怎么用
- 在血液透析患者中,可考虑监测血清25(OH)D水平以辅助评估脆性骨折风险。
- 维持充足的血清25(OH)D水平可能有助于保护血液透析患者的骨骼健康。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In this study, we investigated the association between serum 25-hydroxyvitamin D (25(OH)D) levels and fracture risk in patients undergoing hemodialysis. Our findings suggest that maintaining adequate serum 25(OH)D levels may be important for preserving bone health even in patients undergoing hemodialysis with impaired renal activation of vitamin D. PURPOSE: Vitamin D deficiency and fragility fractures are highly prevalent among patients undergoing hemodialysis. Low serum 25(OH)D levels are associated with an increased risk of fractures in the general population; however, whether this association persists in patients undergoing hemodialysis with suppressed renal activation of 25(OH)D remains unclear. METHODS: Serum 25(OH)D levels were measured in 292 stable outpatients undergoing maintenance hemodialysis. The association between baseline 25(OH)D status and the incidence of new fragility fractures was investigated. RESULTS: During the median follow-up period of 24 months, 49 (16.8%) fractures occurred. Multivariate Cox regression analyses revealed the significant association of a 10 nmol/L increment in serum 25(OH)D levels with a reduced risk of fractures (adjusted hazard ratio [aHR] 0.83, 95% confidence interval [CI] 0.68-0.99, p = 0.046). When patients were stratified by the median 25(OH)D level, the cumulative fracture incidence rates were 24.3% and 11.9% (aHR 1.87, 95% CI 1.02-3.42, p = 0.041) in the lower- and higher-25(OH)D groups, respectively. CONCLUSION: Lower serum 25(OH)D levels were independently associated with an increased risk of fracture, regardless of traditional fracture risk factors or variables affecting vitamin D status in patients undergoing hemodialysis with impaired renal vitamin D activation. This finding suggests that circulating 25(OH)D levels may serve as a predictor of fracture risk in patients undergoing hemodialysis.
引用
- Hori M, Takahashi H, Kondo C, et al. Impact of serum 25-hydroxyvitamin D levels on fragility fractures in patients undergoing chronic hemodialysis. Osteoporos Int. 2026. PMID: 42509419. doi:10.1007/s00198-026-08160-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。